BioEcho Life Sciences receives growth equity investments from Ampersand Capital Partners
COLOGNE, Germany, March 1, 2022 / PRNewswire / – BioEcho Life Sciences GmbH, an innovative manufacturer of nucleic acid purification solutions for molecular diagnostics and life science research, today announced a minority investment from Ampersand Capital Partners, a private equity firm specializing in growth equity investments in the life sciences and healthcare sectors. Ampersand’s investment … Read more